Open AccessClinical impact, reactogenicity and immunogenicity after the first CoronaVac dose in dialysis patients: a Phase IV prospective study
Author(s) -
José MedinaPestana,
Cínthia Montenegro Teixeira,
Marina Pontello Cristelli,
Adriano Luiz Amiratti,
Sílvia Regina Manfredi,
Hélio TedescoSilva,
Dimas Tadeu Covas
Publication year - 2021
Publication title -
clinical kidney journal
Language(s) - English
Resource type - Journals
eISSN - 2048-8513
pISSN - 2048-8505
DOI - 10.1093/ckj/sfab146
Subject(s) - medicine , reactogenicity , immunogenicity , dialysis , intensive care medicine , prospective cohort study , phase (matter) , immunology , immune system , chemistry , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom